TITLE

Raltegravir plus optimized background therapy suppressed HIV-1 RNA levels

AUTHOR(S)
Volansky, Rob
PUB. DATE
September 2008
SOURCE
Infectious Disease News;Sep2008, Vol. 21 Issue 9, p28
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article highlights the findings published in "The New England Journal of Medicine" which found the effectiveness of combination therapy using raltegravir plus optimized background therapy in providing viral suppression than background therapy alone in people. These findings are said to be the latest data from the BENCHMARK trials which examined the safety and efficacy of raltegravir in patients with human immunodeficiency virus (HIV).
ACCESSION #
34569799

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics